Immunogenicity and safety of 4 doses compared to 3 doses of 13-valent pneumococcal conjugate vaccine in allogeneic hematopoietic stem cell transplantation recipients
Latest Information Update: 12 Dec 2022
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 09 Dec 2022 Status changed from active, no longer recruiting to completed.
- 26 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 02 May 2013 New trial record